Formosa Laboratories, Inc.

Formosa Laboratories, founded in 1995 in Luzhu, Taoyuan, Taiwan, is a CDMO specializing in API, peptide, injectable, and antibody-drug conjugate (ADC) development and manufacturing, with 900+ employees on 69,036 m². USFDA, EDQM, PMDA, and German BGV certified. Key APIs include Vitamin D derivatives, Montelukast, Mycophenolate, and Gadodiamide. Acquired SynChem (Chicago) in 2024.